Postoperative Analgesia Using a Perineural Catheter Versus a Single Nerve Block in Rearfoot Surgery (CATHORNOT)
A Comparative Evaluation of Postoperative Analgesia Using a Perineural Catheter Versus a Single Nerve Block in Rearfoot Surgery
Postoperative pain following hindfoot surgery is often severe and can persist for several days. It frequently leads to the use of systemic analgesics, particularly opioids, whose adverse effects are well known. Furthermore, poorly controlled postoperative pain is a recognized independent risk factor for the development of chronic pain.
Ambulatory perineural catheter techniques, already used in our department for hindfoot surgeries, allow for continuous infusion of local anesthetic. They have demonstrated their efficacy in numerous orthopedic surgeries, but data specific to hindfoot surgery remain limited. It therefore seems appropriate to evaluate whether prolonged analgesia via a perineural catheter improves postoperative pain management and promotes functional recovery.
The study is conducted as a practice evaluation audit. It relies on the collection of data from routine care, without any modification to intraoperative care. This methodology allows for an objective evaluation of the benefits of the perineural catheter compared to a single-injection popliteal sciatic block with local anesthetic, while documenting the frequency and nature of complications associated with the technique (leaks, accidental or intentional catheter removal).
調査の概要
状態
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前：Benjamin DUMARTINET
- 電話番号：+33 241353637
- メール：benjamin.dumartinet@chu-angers.fr
研究場所
-
-
-
Angers、フランス
- University Hospital of Angers
-
コンタクト：
- Benjamin DUMARTINET
- 電話番号：+33 241353637
- メール：benjamin.dumartinet@chu-angers.fr
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Adult patients;
- Patients with an American Society of Anesthesiologists physical status (ASA score) of 1, 2, or 3;
- Patients who have undergone hindfoot surgery;
- Patients capable of completing the questionnaires.
Exclusion Criteria:
- Contraindications to regional anesthesia (known hypersensitivity to the local anesthetic, infection at the injection site, uncontrolled neurological condition);
- Emergency surgery
- Cognitive impairment;
- Uncontrolled psychiatric condition;
- Pregnancy or breastfeeding;
- Substance abuse;
- Use of neuroleptics or lithium;
- Individuals subject to legal guardianship
- Individuals deprived of liberty by judicial or administrative order
- Patients who object to the study.
研究計画
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
局所麻酔
|
All patients are contacted by phone to assess pain during movement and at rest on each of the first 3 days after surgery, as well as their use of various pain medications
regional anesthesia
|
|
ambulatory perineural catheter
|
All patients are contacted by phone to assess pain during movement and at rest on each of the first 3 days after surgery, as well as their use of various pain medications
Use of a perineural catheter for ambulatory analgesia
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Pain on movement using a numerical scale from 0 (no pain) to 10 (maximum pain)
時間枠：Day 1 postoperative
|
Postoperative pain on movement at Day 1. Pain intensity during movement assessed using an 11-point Numerical Rating Scale (NRS; 0 = no pain, 10 = worst possible pain)
|
Day 1 postoperative
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Daily postoperative consumption of morphine equivalents in milligrams
時間枠：Baseline, Day 1, Day 2 and Day 3
|
Daily
|
Baseline, Day 1, Day 2 and Day 3
|
|
Daily postoperative use of non-opioid analgesics
時間枠：Baseline, Day 1, Day 2 and Day 3
|
Daily
|
Baseline, Day 1, Day 2 and Day 3
|
|
postoperative pain at rest using a numerical scale from 0 (no pain) to 10 (maximum pain)
時間枠：Postoperative Day 0 through Postoperative Day 3
|
to assess analgesic efficacy at rest
|
Postoperative Day 0 through Postoperative Day 3
|
|
postoperative pain during mobilization using a numerical scale from 0 (no pain) to 10 (maximum pain)
時間枠：From Baseline to Day 3
|
to evaluate the analgesic efficacy during mobilization
|
From Baseline to Day 3
|
|
Postoperative consumption of morphine equivalents in milligrams
時間枠：Postoperative Day 0 through Postoperative Day 3
|
Cumulative
|
Postoperative Day 0 through Postoperative Day 3
|
|
Postoperative use of non-opioid analgesics
時間枠：Postoperative Day 0 through Postoperative Day 3
|
Cumulative
|
Postoperative Day 0 through Postoperative Day 3
|
|
French Quality of Recovery -15 score (FQoR-15 - from 0 to 150)
時間枠：Postoperative Day 0 through Postoperative Day 2
|
to assess functional recovery and postoperative rehabilitation
|
Postoperative Day 0 through Postoperative Day 2
|
|
Proportion of patients experiencing at least one adverse event related to the regional anesthesia technique
時間枠：Postoperative Day 0 through Postoperative Day 3
|
Accidental or intentional removal of the catheter Leaks at the injection site or in the infusion system Bruise or local infection Falls potentially related to the residual motor block
|
Postoperative Day 0 through Postoperative Day 3
|
|
proportion of patients experiencing at least one postoperative complication following hindfoot surgery
時間枠：Postoperative Day 0 through Postoperative Day 3
|
Readmission to the hospital Consultation with the attending physician for uncontrolled postoperative pain or complications related to the procedure Confirmed infection with antibiotic treatment initiated
|
Postoperative Day 0 through Postoperative Day 3
|
|
length of hospital stay, calculated in whole days
時間枠：Postoperative Day 0 through Postoperative Day 3
|
Duration censored on Day 3 if the patient is still hospitalized on that date
|
Postoperative Day 0 through Postoperative Day 3
|
協力者と研究者
捜査官
- 主任研究者：Benjamin DUMARTINET、University Hospital of Angers
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。